Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor Gene to the risk of inflammatory bowel diseases

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 83, Issue 2, 2011, Pages 76-80

  Przybyłowska, Karolina ^a   Mrowicki, Jerzy ^a   Sygut, Andrzej ^a   Narbutt, Piotr ^a   Dziki, Łukasz ^a   Dziki, Adam ^a   Majsterek, Ireneusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Crohn's disease; inflammatory bowel disease; MIF 173 G C gene polymorphism

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AGED; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLAND; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 79953331812     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-011-0012-x     Document Type: Article

References (19)

1. Kamińska B, Lewandowski P: Rola wybranych czynników środowiskowych w etiopatogenezie nieswoistych zapaleń jelit. Forum Medycyny Rodzinnej 2009; 3(1): 42-48.
2. Matsuura T, West GA, Youngman KR et al.: Immune activation genes in inflammatory bowel disease. Gastroenterology 1993; 104(2): 448-58. (Pubitemid 23033417)
3. Pena AS et al.: Genetics and epidemiology may contribute to understanding the pathogenesis of IBD- a new approach is now indicated. Can J Gastroenterol 1993; 7: 71-75.
4. Ohkawara T, Nishihira J, Takeda H et al.: Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002; 123: 256-70. (Pubitemid 34747546)
5. Murakami H, Akbar SMF, Matsui H et al.: Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001; 31: 337-43. (Pubitemid 32328535)
6. Donn R, Alourfi Z, De Benedetti F et al.: Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthristis. Arthritis Rheum 2002; 46(9): 2402-09.
7. Onodera S, Tanji H, Suzuki K et al.: High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999; 11: 163-67. (Pubitemid 29116556)
8. Donnelly SC, Haslett C, Reid PT et al.: Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320-23. (Pubitemid 27112930)
9. Lan HY, Yang N, Nikolic-Paterson DJ et al.: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000; 57: 499-509. (Pubitemid 30430641)
10. Miterski B. Drynda S, Böschow G et al.: Complex genetic predisposition in adult and juvenile rheumatoid arthrist. BMC Genet 2004 Feb 4; 5: 2.
11. Bucala R: MIF rediscovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 1996; 7: 19-24. (Pubitemid 27202662)
12. Calandra T, Bernhagen J, Metz CN et al.: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
13. Calandra T, Bernhagen J, Mitchell RA et al.: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895-1902. (Pubitemid 24155670)
14. de Jong YP, Abadia-Molina AC, Satoskar AR et al.: Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2: 1061-66. (Pubitemid 33069502)
15. Renner P, Roger T, Calandra T: Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005; 41 Suppl 7: S513-19 (Pubitemid 41598313)
16. Fei BY, Lv HX, Yang JM et al.: Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008; 41(1): 44-47.
17. Nohara H, Okayama N, Inoue N et al.: Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004; 39(3): 242-46. (Pubitemid 38519429)
18. Shiroeda H, Tahara T, Nakamura M et al.: Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine 2010 Aug; 51(2): 173-77.
19. Dambacher J, Staudinger T, Seiderer J et al.: Macrophage migration inhibitory factor (MIF) - 173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Inflamm Bowel Dis. 2007 Jan; 13(1): 71-82. (Pubitemid 46080012)